HIV protease inhibitors in pregnancy : pharmacology and clinical use.
about
HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restrictionRisk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.Darunavir for Use in Pregnant Women with HIV.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Adverse effects of antiretroviral therapy in pregnant women infected with HIV in Brazil from 2000 to 2015: a cohort study
P2860
HIV protease inhibitors in pregnancy : pharmacology and clinical use.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HIV protease inhibitors in pregnancy : pharmacology and clinical use.
@en
type
label
HIV protease inhibitors in pregnancy : pharmacology and clinical use.
@en
prefLabel
HIV protease inhibitors in pregnancy : pharmacology and clinical use.
@en
P2860
P1433
P1476
HIV protease inhibitors in pregnancy : pharmacology and clinical use.
@en
P2093
Mona R Loutfy
Nisha Andany
P2860
P2888
P304
P356
10.1007/S40265-013-0017-3
P577
2013-03-01T00:00:00Z
P6179
1009513469